NCT00881621 2025-03-03Lapatinib and Capecitabine for Second Line Treatment of Pancreas CancerGeorgetown UniversityPhase 2 Terminated17 enrolled 10 charts
NCT00447122 2022-03-08BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary CancerBrown UniversityPhase 1 Terminated25 enrolled 9 charts
NCT00962312 2014-12-31Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerCancer Trials IrelandPhase 2 Completed9 enrolled